146 related articles for article (PubMed ID: 17416362)
1. Modulation of nuclear internalization of Tat peptides by fluorescent dyes and receptor-avid peptides.
Shen D; Liang K; Ye Y; Tetteh E; Achilefu S
FEBS Lett; 2007 May; 581(9):1793-9. PubMed ID: 17416362
[TBL] [Abstract][Full Text] [Related]
2. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
Vivès E; Brodin P; Lebleu B
J Biol Chem; 1997 Jun; 272(25):16010-7. PubMed ID: 9188504
[TBL] [Abstract][Full Text] [Related]
3. Translocation and nuclear accumulation of monomer and dimer of HIV-1 Tat basic domain in triticale mesophyll protoplasts.
Chugh A; Eudes F
Biochim Biophys Acta; 2007 Mar; 1768(3):419-26. PubMed ID: 17214959
[TBL] [Abstract][Full Text] [Related]
4. Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models.
Barnett EM; Elangovan B; Bullok KE; Piwnica-Worms D
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2589-95. PubMed ID: 16723475
[TBL] [Abstract][Full Text] [Related]
5. Translocation of the cell-penetrating Tat peptide across artificial bilayers and into living cells.
Curnow P; Mellor H; Stephens DJ; Lorch M; Booth PJ
Biochem Soc Symp; 2005; (72):199-209. PubMed ID: 15649143
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells.
Potocky TB; Menon AK; Gellman SH
J Biol Chem; 2003 Dec; 278(50):50188-94. PubMed ID: 14517218
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of intracellularly acting peptides conjugated reversibly to Tat.
Begley R; Liron T; Baryza J; Mochly-Rosen D
Biochem Biophys Res Commun; 2004 Jun; 318(4):949-54. PubMed ID: 15147964
[TBL] [Abstract][Full Text] [Related]
9. Permeation peptide conjugates for in vivo molecular imaging applications.
Bullok KE; Gammon ST; Violini S; Prantner AM; Villalobos VM; Sharma V; Piwnica-Worms D
Mol Imaging; 2006; 5(1):1-15. PubMed ID: 16779965
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
Josephson L; Tung CH; Moore A; Weissleder R
Bioconjug Chem; 1999; 10(2):186-91. PubMed ID: 10077466
[TBL] [Abstract][Full Text] [Related]
11. Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
Cornelissen B; Hu M; McLarty K; Costantini D; Reilly RM
Nucl Med Biol; 2007 Jan; 34(1):37-46. PubMed ID: 17210460
[TBL] [Abstract][Full Text] [Related]
12. Internalization of Jembrana disease virus Tat: possible pathway and implication.
Deng G; Qiao W; Su Y; Sha R; Geng Y; Chen Q
Virus Res; 2006 Nov; 121(2):122-33. PubMed ID: 16870296
[TBL] [Abstract][Full Text] [Related]
13. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide.
Bhorade R; Weissleder R; Nakakoshi T; Moore A; Tung CH
Bioconjug Chem; 2000; 11(3):301-5. PubMed ID: 10821645
[TBL] [Abstract][Full Text] [Related]
14. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
15. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
Fang B; Jiang L; Zhang M; Ren FZ
Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
[TBL] [Abstract][Full Text] [Related]
16. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
Kaplan IM; Wadia JS; Dowdy SF
J Control Release; 2005 Jan; 102(1):247-53. PubMed ID: 15653149
[TBL] [Abstract][Full Text] [Related]
17. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
18. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells.
Snyder EL; Dowdy SF
Curr Opin Mol Ther; 2001 Apr; 3(2):147-52. PubMed ID: 11338927
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides: tools for intracellular delivery of therapeutics.
Deshayes S; Morris MC; Divita G; Heitz F
Cell Mol Life Sci; 2005 Aug; 62(16):1839-49. PubMed ID: 15968462
[TBL] [Abstract][Full Text] [Related]
20. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways.
Ignatovich IA; Dizhe EB; Pavlotskaya AV; Akifiev BN; Burov SV; Orlov SV; Perevozchikov AP
J Biol Chem; 2003 Oct; 278(43):42625-36. PubMed ID: 12882958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
